from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3509c/ilvX

LFCtreatmentdescriptionclass of inhibitor

-0.176

Amikacinug/mL Amikacintranslation

-0.608

Cap5-10ug/mL Capreomycintranslation

-0.573

Rox10-50 ug/mL Roxithromycintranslation

-0.132

SM2-5 ug/mL Streptomycintranslation

-1.485

Tet5-10 ug/mL Tetracyclinetranslation

1.313

Rif0.2-5ug/mL Rifampicintranscription

0.236

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.334

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.790

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.615

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.165

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.296

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.883

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.022

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.443

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.334

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.078

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.339

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.399

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.464

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.895

KCN5-20 ug/mL Potassium cyaniderespiration

0.123

NaN30.2-2 mM Sodium aziderespiration

0.278

Nigericin50 uM Nigericinrespiration

-0.408

TRC10-150 ug/mL Triclosanrespiration

-2.015

TRZ10-25 ug/mL Thioridazinerespiration

-2.353

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.215

menadione6-10 ug/mL Menadionerespiration

0.095

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.434

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.507

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.347

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.680

NRP_1Non-replicating persistence stage 1dosRassociated

0.097

Amp0.2mg/mL AmpicillincellWall

-0.015

Cephalexin20-100 ug/mL CephalexincellWall

0.201

Cerulenin0.32-5 ug/mL CerulenincellWall

1.306

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.404

EMB10-20 ug/mL EthambutolcellWall

0.385

Eta12-40 ug/mL EthionamidecellWall

0.427

INH0.2-0.4 ug/mL IsoniazidcellWall

1.015

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.694

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.249

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.825

BZA0.12 mg/mL BenzamidearomaticAmides

0.532

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.043

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.133

H2O24 mM hydrogen peroxideDNAdamaging

0.376

Levo10 ug/mL LevofloxacinDNAdamaging

0.162

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.656

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.706

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.567

UVUV-irradiationDNAdamaging

-0.677

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.023

Antimycin12.5-50 ug/mL Antimycin A?

-0.045

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.289

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.170

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.727

PA8240.2-2 ug/mL PA-824?

-0.261

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.289

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.026

Verapamil50 uM Verapamil?

0.478

mercaptoethanol2 mM 2-Mercaptoethanol?

0.402

methoxatin10-20 ug/mL Methoxatin?